IL‑18 improves the expansion and functional fitness of human Vδ1 T cells for superior solid tumor immunotherapy
Human Vδ1 T cells represent promising candidates for allogeneic adoptive immunotherapy due to their MHC-independent tumor recognition and inherent tissue tropism. However, their clinical translation is hampered by their low frequency in peripheral blood and the challenge of generating sufficient functional cells...